Synthesis of pregnane derivatives, their cytotoxicity on LNCaP and PC-3 cells, and screening on 5α-reductase inhibitory activity

Molecules

Volumn 14, Issue 11, 2009, Pages 4655-4668

  Kim, Sujeong ^a   Ma, Eunsook ^a  

^a Catholic University of Daegu   (South Korea)

Author keywords

20 oxime pregnanes; 5 reductase inhibitor; Epoxypregnanes; LNCaP; PC 3

Indexed keywords

PREGNANE DERIVATIVE; STEROID 5ALPHA REDUCTASE;

ARTICLE; CELL SURVIVAL; CHEMICAL STRUCTURE; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; MALE; PROSTATE TUMOR; SYNTHESIS; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL SURVIVAL; HUMANS; MALE; MOLECULAR STRUCTURE; PREGNANES; PROSTATIC NEOPLASMS; TESTOSTERONE 5-ALPHA-REDUCTASE;

EID: 73349088133     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules14114655     Document Type: Article

References (22)

1. 4-5β-reductase. Steroids 1972, 20, 215-222.
2. Cabeza, M.; Flores, E.; Heuze, I.; Sanchez, M.; Bratoeff, E.; Ramirez, E.; Francolugo, V. A. Novel 17-substituted pregnadiene derivatives as 5α-reductase inhibitors and their binding affinity for the androgen receptor. Chem. Pharm. Bull. 2004, 52, 535-539.
3. Andersson, S. R.; Bishop, R. W.; Russell, D. W. Expression cloning and regulation of steroid 5α-reductase, an enzyme essential for male sexual differentiation. J. Biol. Chem. 1989, 264, 16249-16255.
4. Andersson, S.; Russell, D. W. Structural and biochemical properties of cloned expressed human and rat steroid 5α-reductase. Proc. Natl. Acad. Sci. USA 1990, 87, 3640-3644.
5. Russell, D. W.; Wilson, J. D. Steroid 5alpha-reductase: Two genes/two enzymes. Ann. Rev. Biochem. 1994, 63, 25-61.
6. Thigpen, A. E.; Silver, R. I.; Guileyardo, J. M.; Casey, M.; McConnel. J. D.; Russell, D. W. Tissue distribution and ontogeny of steroid 5alpha-reductase isozyme expression. J. Clin. Invest. 1993, 92, 903-910.
7. Hartmann, R. W.; Hector, M.; Haidar, S.; Ehmer, P. B.; Reichert, W.; Jose, J. Synthesis and evaluation of novel steroidal oxime inhibitors of P450 17 (17α-hydroxylase/C17, 20-lyase) and 5α-reductase types 1 and 2. J. Med. Chem. 2000, 43, 4266-4277.
8. Ramírez, E.; Cabeza, M.; Heuze, I.; Gutierrez, E.; Bratoeff, E.; Membrillo, M.; Lira, A. Synthesis and pharmacological evaluation of new 16-methyl pregnenolone derivatives. Chem. Pharm. Bull. 2002, 50, 15-20.
9. Audia, J. E.; Lawhorn, D. E.; Deeter, J. B. Synthesis of the individual enantiomers of the benzoquinolinone human type 1 steroid 5α-reductase inhibitors LY191704 and LY266111. Tetrahedron Lett. 1993, 34, 7001-7004.
10. Bologna, M.; Muzi, P.; Biordi, L.; Festuccia, C.; Vicentini, C. Antiandrons and 5alphareductaseinhibition of the proliferation rate in PC 3 and DU 145 human prostatic cancer cell lines. Curr. Ther. Res. 1991, 51, 799-813.
11. Jones, C. D.; Audia, J. E.; Lawhorn, D. E.; McQuaid, L. A.; Neubauer, B. L.; Pike, A. J.; Pennington, P. A.; Stamm, N. B.; Toomey, R. E.; Hirsch, K. S. Nonsteroidal inhibitors of human type I steroid 5α-reductase. J. Med. Chem. 1993, 36, 421-423.
12. Bologna, M.; Muzi, P.; Biordi, L.; Festuccia, C.; Vicentini, C. Finasteride dose-dependently reduces the proliferation rate of the LNCaP human prostatic cancer cell line in vitro. Urology 1995, 45, 282-290.
13. Kurup, A.; Garg, R.; Hansch, C. Comparative QSAR analysis of 5α-reductase inhibitors. Chem. Rev. 2000, 100, 909-924.
14. Sudduth, S. L.; Koronkowski, M. J. Finasteride The first 5 alpha-reductase inhibitor. Pharmacotherapy 1993, 309-325.
15. Lazier, C. B.; Thomas, L. N.; Douglas, R. C.; Vessey, J. P.; Rittmaster, R. S. Dutasteride, the dual 5 α-reductase inhibitor, inhibits androgen action and promotes cell death in the LNCaP prostate cancer cell line. Prostate 2004, 58, 130-144.
16. McCrohan, A. M.; Morrissey, C.; O'Keane, C.; Mulligan, N.; Watson, C.; Smith, J.; Fitzpatrick, J. M.; Watson, R. W. Effects of the dual 5 α-reductase inhibitor dutasteride on apoptosis in primary cultures of prostate cancer epithelial cells and cell lines. Cancer 2006, 106, 2743-2752.
17. Ling, Y.; Li, J.; Liu, Y.; Wang, X.; Klus, G. T.; Marat, K.; Nnane, I. P.; Brodie, A. M. H. Synthesis and in vivo acting of some epimeric 20α-hydroxy, 20-oxime and aziridine pregnene derivatives as inhibitors of human 17α-hydroxylase/C17, 20-lyase and 5α-reductase. Bioorg. Med. Chem. 1998, 6, 1683-1693.
18. Victor, P. O.; Cabeza, M.; Bratoeff, E.; Heuze, I.; Sanchez, M.; Ramirez, E.; Elia, N. R. New 5-reductase inhibitors: In vitro and in vivo effects. Steroids 2005, 70, 217-224.
19. Cruz-Silva, M. M.; Riva, S.; Sáe-Melo, M. L. Highly selective lipase-mediated diastereomeric 5, 6-epoxysteroids. Tetrahedron Asymmetry 2004, 15, 1173-1179.
20. Ma, E.; Kim, E. Epoxidation and reduction of DHEA, 1, 4, 6-androstatrien-3-one and 4, 6-androstadiene-3β, 17β-diol. Molecules 2005, 10, 572-582.
21. Jang, S.; Lee, Y.; Hwang, S. L.; Lee, M. H.; Park, S. J.; Lee, I. H.; Kang, S.; Roh, S. S.; Seo, Y. J.; Park, J. K.; Lee, J. H.; Lim, CD. Establishment of type II 5α-reductase over-expressing cell line as an inhibitor screening model. J. Steroid Biochem. Mol. Biol. 2007, 107, 245-252.
22. Smith, H. E.; Smith, R. G.; Toft, D. O.; Neergaaed, J. R.; Burrows, E. P.; O'Malley, B. W. Binding of steroids to progesterone receptor proteins in chick oviduct and human uterus. J. Biol. Chem. 1974, 249, 5924-5932. © 2009